Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC4419 for Radiation-Induced Oral Mucositis in HNC
NCT02508389Phase 2Completed
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Oct 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of avasopasem manganese in oral mucositis (OM), sponsored by Galera Therapeutics, Inc.. Started Oct 2015; status: completed.
02
Drugs
avasopasem manganese
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02508389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508389.